Middle East respiratory syndrome (MERS) is a viral respiratory illness caused by the MERS coronavirus that is primarily characterized by fever, cough, and shortness of breath, with a potential to lead to severe complications and high mortality rates.
Hyperbaric oxygen therapy may potentially alleviate respiratory distress and enhance recovery in MERS patients by delivering oxygen-rich environment to damaged tissues and supporting the immune system’s ability to combat the viral infection.